分支型胸腹主动脉瘤修复术后肾功能中期结局
本研究评估了113例接受分支型腔内修复(BEVAR)的胸腹主动脉瘤患者围术期及随访期间急慢性肾功能不全的发生率与影响。术后急性肾损伤(AKI)发生率为36%,2年内多数患者肾功能恢复,但1年和2年慢性肾病(CKD)分期进展分别见于24%和32.7%的患者,7例(6.7%)需永久透析。推荐采用分期手术、早期干预肾分支并发症和定期监测以改善结局。
要点
- BEVAR术后AKI发生率约36%,多数2年内肾功能恢复。
- 1年和2年CKD分期进展率分别为24%和32.7%,6.7%需永久透析。
- 分期手术可降低AKI风险,肾分支再干预与CKD进展相关。
核心结论
- BEVAR术后约三分之一患者发生AKI,且与2年后CKD分期进展相关。
- 术前CKD不是术后AKI或围术期结局的危险因素。
- 推荐分期手术预防AKI、早期干预肾分支并发症并定期监测以改善结局。
研究设计与样本
- 单中心回顾性研究,纳入113例接受BEVAR的胸腹主动脉瘤患者(平均年龄71岁,79例男性)。
- 评估基线、术后48小时、出院时及1年和2年的血清肌酐和估算肾小球滤过率,以及围术期结果和随访结局。
主要发现
- 围术期死亡9/113(8%)。
- 术后AKI 41/113(36%),多数患者2年内肾功能恢复。
- 1年和2年CKD分期进展分别见于25/104(24%)和17/52(32.7%)患者。
- 2年随访期间7例(6.7%)需永久透析。
- AKI危险因素包括非分期手术(P = .02)和多器官衰竭(P = .01)。
临床怎么用
- 对BEVAR患者应优先考虑分期手术以降低AKI风险。
- 对肾分支并发症应早期干预以预防CKD进展。
- 术后需定期监测肾功能,尤其对发生AKI的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the incidence and impact of acute and chronic kidney dysfunction after branched endovascular aortic aneurysm repair (BEVAR) perioperatively and during follow-up. METHODS: Patients with a thoracoabdominal aortic aneurysm were treated with BEVAR. Serum creatinine; estimated glomerular filtration rate at baseline, after 48 hours, at discharge, and after 1 and two years; perioperative results; and outcome during follow-up were evaluated. RESULTS: Treatment of thoracoabdominal aortic aneurysm using BEVAR was performed in 113 patients (mean age, 71 years; 79 male) with 434 side branches and two additional fenestrations (0.46%) for renovisceral perfusion. Sixty patients (53%) underwent staged procedures with temporary aneurysm sac perfusion and secondary side branch completion. Perioperative mortality was 9 of 113 (8%). Postoperative acute kidney injury (AKI) was observed in 41 of 113 patients (36%) with recovery of renal function after 2 years in most patients. However, chronic kidney disease (CKD) stage progression after 1 and 2 years was observed in 25 of 104 patients (24%) and 17 of 52 patients (32.7%), respectively. Seven patients (6.7%) required permanent dialysis during 2 years of follow-up. Risk factors for AKI were nonstaged procedures (P = .02) and multiorgan failure (P = .01). CKD progression was related to renal branch reinterventions (P = .047), all branch reinterventions (P = .03), and postoperative AKI (P = .001). During follow-up, survival was decreased in patients with AKI, especially in those with nonmalignant diseases (P = .01). CONCLUSIONS: Postoperative AKI after BEVAR was observed in about one-third of patients associated with increased CKD stages after 2 years. Preoperative CKD was not a risk factor for postoperative AKI or perioperative outcome. The prevention of AKI by staged procedures, early interventions for renal side branch complications, and regular surveillance is recommended to improve outcomes.
引用
- Cucuruz B, Kasprzak PM, Gallis K, et al. Midterm outcome of renal function after branched thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2019. PMID: 31791742. doi:10.1016/j.jvs.2019.06.200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。